HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5-O-methyldihydroquercetin

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        Quercetin: 5087
        5-O-methyldihydroquercetin: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        Quercetin: 5087
        5-O-methyldihydroquercetin: 1

Experts

1.	Feng, Weisheng: 1 article (03/2020)
2.	Li, Meng: 1 article (03/2020)
3.	Qi, Man: 1 article (03/2020)
4.	Wang, Yangyang: 1 article (03/2020)
5.	Wu, Yuanyuan: 1 article (03/2020)
6.	Xu, Ruiqi: 1 article (03/2020)
7.	Zeng, Mengnan: 1 article (03/2020)
8.	Zheng, Xiaoke: 1 article (03/2020)

Related Diseases

1.	Acute Kidney Injury (Acute Renal Failure) 03/01/2020 - "5-O-methyldihydroquercetin and cilicicone B isolated from Spina Gleditsiae ameliorate lipopolysaccharide-induced acute kidney injury in mice by inhibiting inflammation and oxidative stress via the TLR4/MyD88/TRIF/NLRP3 signaling pathway."
2.	Inflammation (Inflammations) 03/01/2020 - "5-O-methyldihydroquercetin and cilicicone B isolated from Spina Gleditsiae ameliorate lipopolysaccharide-induced acute kidney injury in mice by inhibiting inflammation and oxidative stress via the TLR4/MyD88/TRIF/NLRP3 signaling pathway."

Related Drugs and Biologics

1.	Lipopolysaccharides